KMBC | KC-Led Clinical Trial on Popular Weight-Loss Drug Named Scientific 'Breakthrough of the Year' [Alh5HGXHwZT]

KMBC | KC-Led Clinical Trial on Popular Weight-Loss Drug Named Scientific 'Breakthrough of the Year' [Alh5HGXHwZT]

| 1h 28m 28s | Video has closed captioning.

A groundbreaking study, led by Mikhail Kosiborod, MD, vice president of research at Saint Luke's Health System, has been named the scientific breakthrough of the year by Science Magazine. The study revealed the popular weight loss drug semaglutide — commonly known as Ozempic and Wegovy — is highly effective at treating heart failure in patients with obesity. The results are likely to be a paradigm shift in treating these patients. The study was the leading presentation at the European Society of Cardiology (ESC) 2023 Congress, the largest cardiovascular conference in the world. Learn more about Saint Luke's: Connect: #keto flo gummies on shark tank #juzfiit avc keto gummies